An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel

Abstract Allergic rhinitis is a frequent presenting problem in primary care in the UK, and has increased in prevalence over the last 30 years. When symptomatic, patients report significant reduction in their quality of life and impairment in school and work performance. Achieving adequate symptom co...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Brian Lipworth, Jon Newton, Bhaskar Ram, Iain Small, Jürgen Schwarze
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Diseases of the respiratory system RC705-779
Acceso en línea:	https://doaj.org/article/6ff24193c29741bfb36b50aedfe7c9c0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6ff24193c29741bfb36b50aedfe7c9c0
record_format	dspace
spelling	oai:doaj.org-article:6ff24193c29741bfb36b50aedfe7c9c02021-12-02T16:19:40ZAn algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel10.1038/s41533-016-0001-y2055-1010https://doaj.org/article/6ff24193c29741bfb36b50aedfe7c9c02017-01-01T00:00:00Zhttps://doi.org/10.1038/s41533-016-0001-yhttps://doaj.org/toc/2055-1010Abstract Allergic rhinitis is a frequent presenting problem in primary care in the UK, and has increased in prevalence over the last 30 years. When symptomatic, patients report significant reduction in their quality of life and impairment in school and work performance. Achieving adequate symptom control is pivotal to successful allergic rhinitis management, and relies mostly on pharmacotherapy. While it is recognised that most mild-moderate allergic rhinitis symptoms can be managed successfully in primary care, important gaps in general practitioner training in relation to allergic rhinitis have been identified. With the availability of new effective combination therapies, such as the novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in a single device (Dymista®; Meda), the majority of allergic rhinitis symptoms can be treated in the primary care setting. The primary objective of this consensus statement is to improve diagnosis and treatment of allergic rhinitis in primary care, and offer guidance on appropriate referral of difficult-to-treat patients into secondary care. The guidance provided herein outlines a sequential treatment pathway for allergic rhinitis in primary care that incorporates a considered approach to improve the management of allergic rhinitis symptoms and improve compliance and patient satisfaction with therapy. Adherence with this care pathway has the potential to limit the cost of providing effective allergic rhinitis management in the UK by avoiding unnecessary treatments and investigations, and avoiding the need for costly referrals to secondary care in the majority of allergic rhinitis cases. The fundamentals presented in this consensus article should apply in most health-care settings.Brian LipworthJon NewtonBhaskar RamIain SmallJürgen SchwarzeNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 27, Iss 1, Pp 1-8 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the respiratory system RC705-779
spellingShingle	Diseases of the respiratory system RC705-779 Brian Lipworth Jon Newton Bhaskar Ram Iain Small Jürgen Schwarze An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel
description	Abstract Allergic rhinitis is a frequent presenting problem in primary care in the UK, and has increased in prevalence over the last 30 years. When symptomatic, patients report significant reduction in their quality of life and impairment in school and work performance. Achieving adequate symptom control is pivotal to successful allergic rhinitis management, and relies mostly on pharmacotherapy. While it is recognised that most mild-moderate allergic rhinitis symptoms can be managed successfully in primary care, important gaps in general practitioner training in relation to allergic rhinitis have been identified. With the availability of new effective combination therapies, such as the novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in a single device (Dymista®; Meda), the majority of allergic rhinitis symptoms can be treated in the primary care setting. The primary objective of this consensus statement is to improve diagnosis and treatment of allergic rhinitis in primary care, and offer guidance on appropriate referral of difficult-to-treat patients into secondary care. The guidance provided herein outlines a sequential treatment pathway for allergic rhinitis in primary care that incorporates a considered approach to improve the management of allergic rhinitis symptoms and improve compliance and patient satisfaction with therapy. Adherence with this care pathway has the potential to limit the cost of providing effective allergic rhinitis management in the UK by avoiding unnecessary treatments and investigations, and avoiding the need for costly referrals to secondary care in the majority of allergic rhinitis cases. The fundamentals presented in this consensus article should apply in most health-care settings.
format	article
author	Brian Lipworth Jon Newton Bhaskar Ram Iain Small Jürgen Schwarze
author_facet	Brian Lipworth Jon Newton Bhaskar Ram Iain Small Jürgen Schwarze
author_sort	Brian Lipworth
title	An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel
title_short	An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel
title_full	An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel
title_fullStr	An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel
title_full_unstemmed	An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel
title_sort	algorithm recommendation for the pharmacological management of allergic rhinitis in the uk: a consensus statement from an expert panel
publisher	Nature Portfolio
publishDate	2017
url	https://doaj.org/article/6ff24193c29741bfb36b50aedfe7c9c0
work_keys_str_mv	AT brianlipworth analgorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel AT jonnewton analgorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel AT bhaskarram analgorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel AT iainsmall analgorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel AT jurgenschwarze analgorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel AT brianlipworth algorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel AT jonnewton algorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel AT bhaskarram algorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel AT iainsmall algorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel AT jurgenschwarze algorithmrecommendationforthepharmacologicalmanagementofallergicrhinitisintheukaconsensusstatementfromanexpertpanel
_version_	1718384174507753472

An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel

Ejemplares similares